Sanofi India Interim Dividend: Set April 25 as Record Date

The manufacturer of pharmaceutical products, Sanofi India Limited, has set April 25, 2025, as the record date for its interim dividend for FY25. On March 18, 2025, Sanofi India declared an interim dividend of ₹117.

Sanofi India Record Date: What Does This Mean For Shareholders?

As Sanofi India has set April 25 as the record date for its interim dividend, meaning that April 24 marks the last day to buy Sanofi India shares to become eligible for the interim dividend. Further, any shares bought on or after April 25 (record date) won’t be eligible for the interim dividend.

Sanofi India Financial Performance

The Diabetes portfolio delivered robust double-digit growth for Toujeo®, alongside a successful launch of Soliqua®, reinforcing confidence in the strength and depth of our comprehensive diabetes offering. Recent strategic partnerships in the Central Nervous System (CNS) and Cardiovascular (CV) segments have laid a solid groundwork for accelerated growth, expanded reach, and performance aligned with expectations.

In Q4 2024, the Company achieved a 21% year-over-year increase in operating profit, reaching ₹108 crores, compared to ₹90 crores in Q4 2023. Progress continues under the ‘India for India’ strategy, driven by go-to-market initiatives, enhanced operational efficiency, and a focus on innovation.

Also Read: Sanofi India MD Rodolfo Hrosz to Step Down on April 30, 2025

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.